Is it appropriate for a 23-year-old male who works out 3–5 times per week to take MK-677 (Ibutamoren)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Do Not Recommend MK-677 for This Patient

I strongly advise against taking MK-677 (Ibutamoren) for a healthy 23-year-old male who works out regularly, as this compound is not FDA-approved for any indication, carries significant health risks, and offers no legitimate benefit over evidence-based exercise and nutrition strategies.

Why MK-677 Is Inappropriate

Regulatory and Safety Status

MK-677 is not FDA-approved for any medical use. The FDA drug label references provided 111 are actually for quetiapine (Seroquel), an antipsychotic medication—this appears to be a database error and highlights the lack of legitimate pharmaceutical oversight for MK-677. This compound exists in a regulatory gray area, often marketed as a "research chemical" or supplement, but it is neither.

Documented Adverse Effects

The available research demonstrates concerning side effects even in controlled settings:

  • Hepatotoxicity: A recent case report documented significant liver enzyme elevation (transaminitis) requiring discontinuation 2. This is particularly concerning for a young, otherwise healthy individual.

  • Metabolic Dysfunction: MK-677 impairs glucose homeostasis. In obese males treated for just 8 weeks, oral glucose tolerance testing showed impaired glucose handling at both 2 and 8 weeks 3. This metabolic disruption is counterproductive to fitness goals.

  • Hormonal Disruption: Co-administration with other performance-enhancing compounds showed dramatic reductions in free testosterone (-85.7%) and total testosterone (-62.3%), along with suppressed follicle-stimulating hormone 4. While this study involved combination use, it demonstrates the potential for significant endocrine disruption.

  • Lipid Profile Deterioration: The same case study showed increases in total cholesterol (+14.8%), triglycerides (+39.2%), LDL-cholesterol (+40.0%), and decreases in HDL-cholesterol (-36.4%) 4. These changes increase cardiovascular risk.

  • Bone Density Reduction: Paradoxically, despite being promoted for anabolic effects, MK-677 use was associated with decreased bone mineral content (-3.6%) and bone mineral density (-2.1%) 4.

Questionable Efficacy for Athletic Goals

While MK-677 does increase IGF-I levels (approximately 40% increase) 53, the practical benefits are limited:

  • In obese subjects, 8 weeks of treatment increased fat-free mass but did not significantly reduce total or visceral fat 3
  • The increase in basal metabolic rate was transient (significant at 2 weeks but not at 8 weeks) 3
  • The compound transiently increased leptin levels, which could paradoxically affect appetite regulation 6

What This Patient Should Do Instead

Evidence-Based Exercise Programming

For a healthy 23-year-old male working out 3-5 times weekly, the established guidelines provide superior, safe approaches 789:

Resistance Training (2-3 days/week):

  • 8-12 repetitions per set at 60-70% of 1-repetition maximum for strength gains
  • 2-4 sets per exercise targeting major muscle groups
  • 48-hour rest between sessions for the same muscle group
  • Progressive overload by increasing resistance, repetitions, or frequency 8

Aerobic Exercise:

  • 150-300 minutes of moderate-intensity OR 75-150 minutes of vigorous-intensity weekly
  • Can be accumulated in bouts throughout the day (the 2018 guidelines removed the previous 10-minute minimum requirement) 9

Nutrition Optimization:

  • Adequate protein intake (typically 1.6-2.2 g/kg body weight for those engaged in resistance training)
  • Appropriate caloric intake matched to training volume and body composition goals
  • Proper hydration before, during, and after exercise 7

Why This Approach Is Superior

The evidence-based exercise and nutrition approach:

  • Carries no risk of hepatotoxicity, hormonal disruption, or metabolic dysfunction
  • Provides sustainable, long-term improvements in strength, body composition, and cardiovascular health
  • Improves multiple health outcomes including bone density, metabolic health, and cardiovascular function 9
  • Costs nothing beyond gym access and proper nutrition

Critical Pitfalls to Avoid

  1. Don't fall for marketing claims: MK-677 is often promoted online with exaggerated claims about muscle growth and fat loss that are not supported by rigorous evidence in healthy, athletic populations.

  2. Recognize the lack of long-term safety data: Most studies are short-term (weeks to months) in specific populations (elderly, obese). There is virtually no data on long-term use in young, healthy individuals.

  3. Understand detection in drug testing: MK-677 is detectable in hair samples for extended periods and is prohibited by most athletic organizations 10. Use could result in competition bans.

  4. Be aware of product contamination: As an unregulated compound, products sold as MK-677 may contain unknown contaminants or incorrect dosages.

Bottom Line

For a healthy 23-year-old male, the risks of MK-677 far outweigh any potential benefits. The documented cases of liver toxicity 2, metabolic disruption 3, and hormonal suppression 4 make this an unacceptable choice when safe, effective, evidence-based alternatives exist. Focus on optimizing training programming, nutrition, recovery, and consistency—these factors will produce superior results without the health risks associated with experimental compounds.

References

2
Research

Hepatotoxicity induced by MK-677.

BMJ case reports, 2025

Related Questions

Is ibutamoren (MK‑677) an appropriate substitute for FDA‑approved recombinant human growth hormone (somatropin) in treating growth‑hormone deficiency?
What probiotic and prebiotic products (market names) are available in India for a daily synbiotic regimen to prevent hepatic encephalopathy in at‑risk patients?
In a patient with a 14‑month history of lymphocytosis, recent polychromasia, and five months of dizziness and vertigo, does the monoclonal B‑cell lymphocytosis (CD5‑positive, CD10‑negative, kappa‑restricted, absolute count ~2,600/µL) explain these symptoms, and what diagnostic work‑up and management steps are recommended?
Given my lipid panel showing total cholesterol 218 mg/dL, HDL cholesterol 37 mg/dL, LDL cholesterol 150 mg/dL, triglycerides 154 mg/dL, and non‑HDL cholesterol 181 mg/dL, what treatment plan should I follow?
How should a patient with a systolic blood pressure >200 mm Hg be managed, including immediate antihypertensive therapy and urgent ophthalmology follow‑up?
When can a child with impetigo return to daycare after starting appropriate oral antibiotic therapy?
How long should high‑dose amoxicillin be administered for streptococcal pharyngitis and acute otitis media?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.